These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22292379)

  • 1. [Case study of Chinese medicine after listing of pharmacovigilance].
    Xiang Y; Xie Y; Yi D
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2836-9. PubMed ID: 22292379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacovigilance of major parmaceutical innovation].
    Xiang Y; Xie Y; Yi D
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2831-5. PubMed ID: 22292378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacovigilance in Traditional Chinese Medicine safety surveillance.
    Wang H; Ye X; Gao Q; Wu C; Qian Y; Luo B; Sun Y; He J
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):357-61. PubMed ID: 19253921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thought on several problems of post-marketing herbs clinical evaluation in special populations].
    Zhou A; Lian F
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2776-8. PubMed ID: 22292362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine].
    Fu Y; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2904-6. PubMed ID: 22292397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine.
    Wu T; Shang H; Bian Z; Zhang J; Li T; Li Y; Zhang B
    J Evid Based Med; 2010 Feb; 3(1):11-7. PubMed ID: 21349035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database.
    Li X; Thai S; Lu W; Sun S; Tang H; Zhai S; Wang T
    Int J Clin Pharm; 2018 Aug; 40(4):921-927. PubMed ID: 30051226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and realization of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine].
    Zhuang Y; Xie B; Weng S; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2883-7. PubMed ID: 22292392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thinking on risk assessment and risk management of post-marketing Chinese medicine].
    Yu X; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):262-4. PubMed ID: 22737865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines List (2004 edition) of China: an overview on published literatures.
    Wang L; Yuan Q; Marshall G; Cui X; Cheng L; Li Y; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 May; 3(2):95-104. PubMed ID: 21349051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of nested case-control study on safe evaluation of post-marketing traditional Chinese medicine injection].
    Xiao Y; Zhao Y; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2796-8. PubMed ID: 22292368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting traditional Chinese medicine morbidity--A University of Technology, Sydney, project with an emphasis on developing standards for testing and reporting data.
    Meier PC; Rogers C
    J Altern Complement Med; 2006; 12(6):529-34. PubMed ID: 16884343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine].
    Zhuang Y; Xie B; Weng S; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2880-2. PubMed ID: 22292391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation.
    Hauben M; Reich L
    J Clin Pharmacol; 2005 Apr; 45(4):378-84. PubMed ID: 15778418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced hyperglycemia: a study in the French pharmacovigilance database].
    Chebane L; Tavassoli N; Bagheri H; Montastruc JL;
    Therapie; 2010; 65(5):447-58. PubMed ID: 21144480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.